What’s more interesting is that circulating eotaxin levels combine hepatic steatosis could well predict carotid intima-media thickness (cIMT) in obese patients with nonalcoholic fatty liver disease, a distinct CAD risk factor [34]. Here, CCL11 is linked to metabolic dysfunction-associated steatotic liver disease.